Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/12/1037
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
||
|
NDF-RT |
N0000192338
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
EMPLICITI (AUTHORIZED: MULTIPLE MYELOMA)
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
||
|
FDA ORPHAN DRUG |
348411
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
||
|
WHO-ATC |
L01XC23
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
||
|
NCI_THESAURUS |
C129822
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N0000192337
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | SLAMF7-directed Antibody Interactions [MoA] | ||
|
100000144872
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
9074
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
5072
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
1351PE5UGS
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
1351PE5UGS
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
ELOTUZUMAB
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
915296-00-3
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
SUB121695
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
CHEMBL1743010
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
DB06317
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
1726104
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | RxNorm | ||
|
C66982
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
TT-69
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
Elotuzumab
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY | |||
|
m11900
Created by
admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
|
PRIMARY |
ACTIVE MOIETY